Literature DB >> 15505042

Pdlim2, a novel PDZ-LIM domain protein, interacts with alpha-actinins and filamin A.

Mario Torrado1, Vladimir V Senatorov, Ritu Trivedi, Robert N Fariss, Stanislav I Tomarev.   

Abstract

PURPOSE: To characterize properties of Pdlim2, a novel PDZ and LIM domain-containing protein.
METHODS: cDNA encoding Pdlim2 was identified in a cDNA library of transcripts expressed in the tissues of the rat eye irido-corneal angle. The expression pattern of the Pdlim2 gene was studied by Northern blot analysis and in situ hybridization. Proteins interacting with Pdlim2 were identified by pull-down assay and mass spectrometry. Intracellular localization of Pdlim2 was investigated by confocal microscopy.
RESULTS: Rat Pdlim2 protein belongs to the ALP subfamily of proteins containing the PDZ domain in the N-terminal portion and the LIM domain in the C-terminal portion of the protein. The Pdlim2 gene was specifically expressed in the corneal epithelial cells, but not in the corneal stroma and endothelium nor in other ocular tissues. Pdlim2 was also expressed in the lung. In rat corneal and lung extracts, alpha-actinin-1, alpha-actinin-4, filamin A, and myosin heavy polypeptide 9 were co-immunoprecipitated with Pdlim2. Myosin VI was co-immunoprecipitated with Pdlim2 from corneal but not lung extracts. alpha-Actinins were the most abundant among immunoprecipitated proteins. Direct interaction of Pdlim2 with alpha-actinins and filamin was confirmed using pull-down assays and gel overlay assay with purified proteins. Pdlim2 and alpha-actinins were co-localized mainly to stress fibers after transfection into COS-7 cells. In transfected COS-7 cells, complexes of Pdlim2 and alpha-actinin-1 were preferentially located along the basal aspect.
CONCLUSIONS: These results suggest that Pdlim2, like other ALP subfamily members, may act as an adapter that directs other proteins to the cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505042     DOI: 10.1167/iovs.04-0721

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

1.  Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein.

Authors:  Olga A Guryanova; Judith A Drazba; Elena I Frolova; Peter M Chumakov
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Unusual binding interactions in PDZ domain crystal structures help explain binding mechanisms.

Authors:  Jonathan M Elkins; Carina Gileadi; Leela Shrestha; Claire Phillips; Jing Wang; João R C Muniz; Declan A Doyle
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

3.  Pull-down Assay on Streptavidin Beads and Surface Plasmon Resonance Chips for SWATH-MS-based Interactomics.

Authors:  Josef Maryáš; Jakub Faktor; Lenka Čápková; Petr Müller; Petr Skládal; Pavel Bouchal
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 4.069

4.  Different Evolutionary Trajectories of Two Insect-Specific Paralogous Proteins Involved in Stabilizing Muscle Myofibrils.

Authors:  Nicanor González-Morales; Thomas W Marsh; Anja Katzemich; Océane Marescal; Yu Shu Xiao; Frieder Schöck
Journal:  Genetics       Date:  2019-05-13       Impact factor: 4.562

5.  Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth.

Authors:  Gary Loughran; Nollaig C Healy; Patrick A Kiely; Merei Huigsloot; Nancy L Kedersha; Rosemary O'Connor
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

6.  Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.

Authors:  Zhaoxia Qu; Jing Fu; Pengrong Yan; Jing Hu; Shi-Yuan Cheng; Gutian Xiao
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

7.  NF-κB and cancer: a paradigm of Yin-Yang.

Authors:  Gutian Xiao; Jing Fu
Journal:  Am J Cancer Res       Date:  2010-12-06       Impact factor: 6.166

8.  Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis.

Authors:  J Fu; P Yan; S Li; Z Qu; G Xiao
Journal:  Oncogene       Date:  2010-09-13       Impact factor: 9.867

Review 9.  ALP/Enigma PDZ-LIM domain proteins in the heart.

Authors:  Ming Zheng; Hongqiang Cheng; Indroneal Banerjee; Ju Chen
Journal:  J Mol Cell Biol       Date:  2009-12-30       Impact factor: 6.216

10.  Human T-cell leukemia virus type I-mediated repression of PDZ-LIM domain-containing protein 2 involves DNA methylation but independent of the viral oncoprotein tax.

Authors:  Pengrong Yan; Zhaoxia Qu; Chie Ishikawa; Naoki Mori; Gutian Xiao
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.